Although the medical device company saw higher unit volumes, these gains were offset by unfavorable changes in price and foreign currency exchange rates. Stryker saw an overall sales gain of 1 percent totaling $2.1 billion for this quarter.
More Articles on Orthopedic Devices:
Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B
Brian McCollum to Lead Orthofix Spine Global Business Unit
Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
